JACK:NASDAQJack In The Box Inc. Analysis
Data as of 2026-05-19 - not real-time
$10.78
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Jack in the Box (JACK) trades marginally above its 20‑day simple moving average while remaining below its 50‑day SMA, indicating a price that is still tethered to short‑term trend baselines. Momentum indicators reveal an RSI in the oversold zone and a bearish MACD histogram, both suggesting limited upside pressure. Current price sits near the lower end of the recent support band and well beneath the prior resistance threshold, framing the stock in a constrained range.
The market shows an increasing volume trend coupled with a neutral overall trend direction, yet the 30‑day volatility metric registers at a markedly high level, underscoring pronounced price swings. A beta well above one points to heightened sensitivity to broader market moves, and the fear/greed gauge flags an "Extreme Greed" sentiment, aligning with the sizable max drawdown observed. Liquidity appears moderate given the average daily volume versus market‑cap size.
Fundamentally, the company posted a revenue dip year‑over‑year, generated negative trailing EPS, and carries a forward EPS that modestly offsets the loss narrative. The balance sheet reflects a leveraged stance with substantial debt relative to negligible equity, a negative book‑value per share, and a price‑to‑book ratio that is effectively below zero. Despite a headline‑grabbing dividend yield, the payout ratio is zero and earnings are negative, rendering the dividend stream unsustainable. Consequently, the stock leans toward an undervalued classification with a value‑oriented tilt rather than growth, as price targets sit above current trading levels.
The market shows an increasing volume trend coupled with a neutral overall trend direction, yet the 30‑day volatility metric registers at a markedly high level, underscoring pronounced price swings. A beta well above one points to heightened sensitivity to broader market moves, and the fear/greed gauge flags an "Extreme Greed" sentiment, aligning with the sizable max drawdown observed. Liquidity appears moderate given the average daily volume versus market‑cap size.
Fundamentally, the company posted a revenue dip year‑over‑year, generated negative trailing EPS, and carries a forward EPS that modestly offsets the loss narrative. The balance sheet reflects a leveraged stance with substantial debt relative to negligible equity, a negative book‑value per share, and a price‑to‑book ratio that is effectively below zero. Despite a headline‑grabbing dividend yield, the payout ratio is zero and earnings are negative, rendering the dividend stream unsustainable. Consequently, the stock leans toward an undervalued classification with a value‑oriented tilt rather than growth, as price targets sit above current trading levels.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- bearish MACD histogram
- oversold RSI
- price near support
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- high dividend yield but unsustainable
- leveraged balance sheet
- neutral trend direction
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- persistent revenue decline
- negative earnings
- elevated beta and volatility
Key Metrics & Analysis
Financial Health
Revenue Growth-4.30%
Profit Margin2.49%
P/E Ratio2.9
ROA4.35%
P/B Ratio-0.2
Op. Cash Flow$96.9M
Free Cash Flow$-378000
Technical Analysis
TrendNeutral
RSI36.4
Support$10.45
Resistance$14.27
MA 20$12.71
MA 50$12.03
MA 200$17.17
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61
Valuation
Target Price$18.26
Upside/Downside69.43%
GradeUndervalued
TypeValue
Dividend Yield15.71%
Risk Assessment
Beta1.65
Volatility79.56%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.